Post-discharge prognosis of patients admitted to hospital for heart failure by world region, and national level of income and income disparity (REPORT-HF): a cohort study.

[1]  M. K. Othman,et al.  Regional Variation of Mortality in Heart Failure With Reduced and Preserved Ejection Fraction Across Asia: Outcomes in the ASIAN‐HF Registry , 2019, Journal of the American Heart Association.

[2]  Akshay S. Desai,et al.  Income Inequality and Outcomes in Heart Failure: A Global Between-Country Analysis. , 2019, JACC. Heart failure.

[3]  W. Shimizu,et al.  Heart failure with preserved ejection fraction in Asia , 2018, European journal of heart failure.

[4]  R. Califf,et al.  Relationship Between Enrolling Country Income Level and Patient Profile, Protocol Completion, and Trial End Points: From the ASCEND-HF Trial , 2018, Circulation. Cardiovascular quality and outcomes.

[5]  Katrina Poppe,et al.  Mortality associated with heart failure with preserved vs. reduced ejection fraction in a prospective international multi-ethnic cohort study , 2018, European heart journal.

[6]  Mark D. Huffman,et al.  Global mortality variations in patients with heart failure: results from the International Congestive Heart Failure (INTER-CHF) prospective cohort study. , 2017, The Lancet. Global health.

[7]  Paolo Vineis,et al.  Socioeconomic status and the 25 × 25 risk factors as determinants of premature mortality: a multicohort study and meta-analysis of 1·7 million men and women , 2017, The Lancet.

[8]  W. Shimizu,et al.  Regional and ethnic differences among patients with heart failure in Asia: the Asian sudden cardiac death in heart failure registry. , 2016, European heart journal.

[9]  S. Solomon,et al.  Geographic variations in the PARADIGM-HF heart failure trial , 2016, European heart journal.

[10]  G. Filippatos,et al.  European Society of Cardiology Heart Failure Long‐Term Registry (ESC‐HF‐LT): 1‐year follow‐up outcomes and differences across regions , 2016, European journal of heart failure.

[11]  C. O'connor,et al.  Geographic Differences in Patients in a Global Acute Heart Failure Clinical Trial (from the ASCEND-HF Trial). , 2016, The American journal of cardiology.

[12]  T. Nair,et al.  Clinical presentation, management, in‐hospital and 90‐day outcomes of heart failure patients in Trivandrum, Kerala, India: the Trivandrum Heart Failure Registry , 2015, European journal of heart failure.

[13]  S. Solomon,et al.  Global variation in clinical profile, management, and post‐discharge outcomes among patients hospitalized for worsening chronic heart failure: findings from the ASTRONAUT trial , 2015, European journal of heart failure.

[14]  K. Dickstein,et al.  International REgistry to assess medical Practice with lOngitudinal obseRvation for Treatment of Heart Failure (REPORT‐HF): rationale for and design of a global registry , 2015, European journal of heart failure.

[15]  S. Solomon,et al.  International Geographic Variation in Event Rates in Trials of Heart Failure With Preserved and Reduced Ejection Fraction , 2015, Circulation.

[16]  Deepak L. Bhatt,et al.  Outcomes in patients with heart failure with preserved, borderline, and reduced ejection fraction in the Medicare population. , 2014, American heart journal.

[17]  A. Zwinderman,et al.  Factors influencing the predictive power of models for predicting mortality and/or heart failure hospitalization in patients with heart failure. , 2014, JACC. Heart failure.

[18]  Mark Woodward,et al.  Heart Failure Care in Low- and Middle-Income Countries: A Systematic Review and Meta-Analysis , 2014, PLoS medicine.

[19]  P. Ponikowski,et al.  International differences in clinical characteristics, management, and outcomes in acute heart failure patients: better short‐term outcomes in patients enrolled in Eastern Europe and Russia in the PROTECT trial , 2014, European journal of heart failure.

[20]  A. Sergeant.  National Heart Failure Audit , 2013 .

[21]  Robert N. Doughty,et al.  The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis. , 2011, European heart journal.

[22]  P. Ponikowski,et al.  EURObservational Research Programme: The Heart Failure Pilot Survey (ESC‐HF Pilot) , 2010, European journal of heart failure.

[23]  Adrian F Hernandez,et al.  Representativeness of a National Heart Failure Quality-of-Care Registry: Comparison of OPTIMIZE-HF and Non–OPTIMIZE-HF Medicare Patients , 2009, Circulation. Cardiovascular quality and outcomes.

[24]  K. Swedberg,et al.  Continental differences in clinical characteristics, management, and outcomes in patients hospitalized with worsening heart failure results from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) program. , 2008, Journal of the American College of Cardiology.

[25]  J. Murabito,et al.  Lifetime Risk for Developing Congestive Heart Failure: The Framingham Heart Study , 2002, Circulation.

[26]  T. Blakely,et al.  What is the lag time between income inequality and health status? , 2000, Journal of epidemiology and community health.

[27]  J. Gower,et al.  Multivariate data analysis , 1972 .